Monashee Investment Management LLC Decreases Stock Holdings in MDxHealth SA (NASDAQ:MDXH)

Monashee Investment Management LLC decreased its holdings in MDxHealth SA (NASDAQ:MDXH - Free Report) by 79.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 208,000 shares of the company's stock after selling 792,000 shares during the quarter. Monashee Investment Management LLC owned about 0.44% of MDxHealth worth $493,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MDXH. Samjo Management LLC raised its stake in shares of MDxHealth by 130.9% in the fourth quarter. Samjo Management LLC now owns 1,824,312 shares of the company's stock worth $4,324,000 after purchasing an additional 1,034,312 shares during the last quarter. Perkins Capital Management Inc. grew its position in MDxHealth by 31.6% during the 4th quarter. Perkins Capital Management Inc. now owns 983,475 shares of the company's stock worth $2,331,000 after purchasing an additional 236,100 shares during the period. Northern Trust Corp purchased a new position in shares of MDxHealth during the 4th quarter valued at about $1,033,000. Renaissance Technologies LLC lifted its holdings in shares of MDxHealth by 715.2% in the 4th quarter. Renaissance Technologies LLC now owns 123,100 shares of the company's stock valued at $292,000 after buying an additional 108,000 shares during the period. Finally, Northern Right Capital Management L.P. acquired a new position in shares of MDxHealth in the 4th quarter valued at about $246,000.

MDxHealth Stock Performance

MDXH stock traded up $0.01 during trading on Monday, hitting $1.73. 9,621 shares of the company traded hands, compared to its average volume of 82,478. MDxHealth SA has a 1 year low of $1.35 and a 1 year high of $3.50. The company has a market cap of $81.57 million, a PE ratio of -1.13 and a beta of 1.29. The stock's 50-day simple moving average is $1.58 and its 200 day simple moving average is $1.86. The company has a debt-to-equity ratio of 3.14, a current ratio of 1.54 and a quick ratio of 1.45.

MDxHealth (NASDAQ:MDXH - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.07. The firm had revenue of $24.74 million during the quarter, compared to analysts' expectations of $22.67 million. MDxHealth had a negative net margin of 49.52% and a negative return on equity of 1,077.84%. On average, equities analysts expect that MDxHealth SA will post -1.15 earnings per share for the current fiscal year.

MDxHealth Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.